Osborn Williams & Donohoe’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-800
Closed -$4K 568
2019
Q1
$4K Buy
+800
New +$5.55K ﹤0.01% 702

Other funds holding PGEN

Osborn Williams & Donohoe's PGEN Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Precigen (PGEN) in Q2 2019, closing a stake of 800 shares — an estimated $4K sold.

Osborn Williams & Donohoe first reported a position in PGEN in Q1 2019 and held it in 1 quarter. The position peaked at $4K in Q1 2019. 162 funds tracked by Wall St. Rank hold PGEN as of Q2 2019.

  • Osborn Williams & Donohoe reported no remaining Precigen position as of Q2 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 800 Precigen shares in Q2 2019, an estimated $4K.
  • Osborn Williams & Donohoe first reported a position in Precigen in Q1 2019 and held it in 1 quarter.
  • Osborn Williams & Donohoe's Precigen position peaked at $4K in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Precigen as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.